about
A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-AnalysisMycobacterium tuberculosis pncA Polymorphisms That Do Not Confer Pyrazinamide Resistance at a Breakpoint Concentration of 100 Micrograms per Milliliter in MGIT.Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosisEvaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment.The potential use of rifabutin for treatment of patients diagnosed with rifampicin-resistant tuberculosisDiscordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impactRapid Pyrazinamide Drug Susceptibility Testing using a Closed-Tube PCR Assay of the Entire pncA gene
P50
Q27011264-AF0804CC-636D-4D3E-A25E-B20A67D1BAEEQ36174022-092C5DF5-6F2E-4460-BFB1-C352ADFA0144Q37133281-3DE485EF-E7B6-4D38-BC9E-D9A5671A832DQ38739933-88D71E7A-5310-40F9-B796-F342DBF49EF4Q60364183-78641B1F-9A0D-416A-A463-B91A6788A5D4Q89521812-FBE5CCBA-70FE-433E-813E-A1DE791B40ADQ90119126-5FCE304A-5204-4006-B07F-A4D15976A8A3
P50
description
researcher ORCID ID = 0000-0002-5956-8384
@en
wetenschapper
@nl
name
Michael G Whitfield
@ast
Michael G Whitfield
@en
Michael G Whitfield
@es
Michael G Whitfield
@nl
type
label
Michael G Whitfield
@ast
Michael G Whitfield
@en
Michael G Whitfield
@es
Michael G Whitfield
@nl
prefLabel
Michael G Whitfield
@ast
Michael G Whitfield
@en
Michael G Whitfield
@es
Michael G Whitfield
@nl
P106
P1153
56844887600
P31
P496
0000-0002-5956-8384